Feasibility of a Developmentally-tailored Mobile App for Tracking Mood and Pain in Children With Migraine
NCT05337930 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2023-10-13
Summary
This study aims to inform the continued development of a mobile app intended to support the treatment of CYP with migraine. After extensive public and patient involvement, Happyr Health has developed a mobile app that allows children and young people to track headache attacks and emotional wellbeing and to access coping techniques. With the use of gamification and storytelling elements, the app aims to engage children to be an active part in tracking and coping with their headaches. The outcomes of this study will inform future adaptations and development cycles of the Happyr Health app.
15 participants aged 10-16 will access the Happyr app for 8 weeks (= intervention). Primary outcomes of acceptability and implementation will be measured via surveys following the 8-week intervention in the app.
Conditions
- Primary Headache Disorder
Interventions
- DEVICE
-
Happyr App
The Happyr app offers three main areas: (A) A mood diary in which a user can keep track of emotional wellbeing by answering three short questions. (B) A pain diary in which a user and supporter can record headache attacks by answering a set of predefined questions whenever a user experiences or has experienced a headache attack. (C) An overview section in which entries from the mood and pain diary are visualized for the user. In this section, a PDF document can also be exported with a summary of data from the symptom diary that can be taken to the clinician. A standardized notification is sent to each user at 6pm local time to remind them about logging their mood and symptoms of a headache attack.
Sponsors & Collaborators
-
The Leeds Teaching Hospitals NHS Trust
collaborator OTHER -
Happyr Ltd
lead INDUSTRY
Principal Investigators
-
Munni Ray · The Leeds Teaching Hospitals NHS Trust
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 10 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-04
- Primary Completion
- 2023-02-28
- Completion
- 2023-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Treatment of Episodic Migraine With AURICular Neuromodulation
NCT06623188 ·Status: RECRUITING ·Phase: NA
-
MigraineManager: An Individualized Self-Management Tool for Adolescents With Migraine
NCT03157739 ·Status: COMPLETED ·Phase: NA
-
A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (App) on Participant Care
NCT03559088 ·Status: COMPLETED ·Phase: NA
-
The Incidents of Weekend Headaches in Children
NCT05218330 ·Status: UNKNOWN
-
Migraine in Adolescents
NCT05654012 ·Status: RECRUITING ·Phase: NA
-
Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine
NCT04604977 ·Status: COMPLETED ·Phase: NA
-
My Healthy Diary - An Electronic Diary for Remote Migraine Monitoring
NCT04828941 ·Status: UNKNOWN ·Phase: NA
-
Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
NCT05769348 ·Status: RECRUITING ·Phase: NA
-
Headstrong Intervention for Pediatric Headache
NCT00269581 ·Status: COMPLETED ·Phase: PHASE3
-
Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine
NCT05738213 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine
NCT05853900 ·Status: COMPLETED ·Phase: NA
-
A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab
NCT04537429 ·Status: COMPLETED ·Phase: PHASE1
-
Facilitating Migraine Medication Adherence and Optimizing Medication Use
NCT02473692 ·Status: WITHDRAWN
-
Biomarker Study in Participants With Migraine
NCT02766517 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction
NCT00487578 ·Status: TERMINATED ·Phase: PHASE4
-
Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache
NCT04369729 ·Status: COMPLETED
-
A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children
NCT00237302 ·Status: COMPLETED ·Phase: PHASE3
-
Biofeedback-VR for Treatment of Chronic Migraine
NCT05720819 ·Status: COMPLETED ·Phase: NA
-
Predicting Migraine Attacks Based on Environmental and Behavioral Changes as Detected From the Smartphone
NCT03762902 ·Status: TERMINATED
-
Protective HA Factors
NCT02748174 ·Status: WITHDRAWN ·Phase: NA
-
Mindfulness-Based Intervention for Adolescents With Chronic Migraine
NCT06414109 ·Status: COMPLETED ·Phase: NA
-
Mindfulness for Adolescents for CM and HFEM
NCT04968093 ·Status: COMPLETED ·Phase: NA
-
Prediction of Migraine Prevention Efficacy Based on Individual's Pain Modulation
NCT02101892 ·Status: COMPLETED ·Phase: NA
-
Prevalence and Determinants of Migraine Among Headache Patients
NCT07038499 ·Status: NOT_YET_RECRUITING
-
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
NCT02991430 ·Status: TERMINATED ·Phase: NA